International Journal of Hematology and Oncology
2018 , Vol 28 , Num 4
Suheyla Aytac ARSLAN, Gonca Altinisik INAN, Ipek Pınar ARAL, Selcan CELIK, Havva KARABUGA, H. Furkan OZTURK
Relationship Between Target Delineation and Surface Dose in Breast Radiotherapy Using Helical Tomotherapy. UHOD , 2018 , 28 , 201-207
Yurday OZDEMIR, Ibrahim ACIBUCI, Erkan TOPKAN The Feasibility of Sparing the Hippocampus and Hypothalamic -Hypophysial Axis During Whole Brain Radiotherapy: A Dosimetric Study. UHOD , 2018 , 28 , 208-216
Ozlem YETMEN DOGAN, Elif GUZEL, Ilker COBAN, Oner SUZER, Nuran BESE Does Lapatinib Increase Pulmonary Toxicity when Concurrently Used with Radiation Therapy? An Experimental Study with Wistar-Albino Rats. UHOD , 2018 , 28 , 217-223
Ulas KUMBASAR, Melih OZERCAN, Sevilay KARAHAN, Erkan DIKMEN, Metin DEMIRCIN, Riza DOGAN Prognostic Significance of the Glasgow Prognostic Score in Patients Undergoing Pulmonary Metastasectomy. UHOD , 2018 , 28 , 224-229
Le Van QUANG, Nguyen Van HIEU, Nguyen Xuan HAU, Nguyen Van HUNG Role of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma in Vietnam. UHOD , 2018 , 28 , 230-237
Mahdiyar IRAVANI SAADI, Nargess ARANDI, Ramin YAGHOBI, Negar AZARPIRA, Bita GERAMIZADEH, Mani RAMZI Up-Regulation of the miR-92a and miR-181a in Patients with Acute Myeloid Leukemia and their Inhibition with Locked Nucleic acid (LNA)-antimiRNA; Introducing c-Kit as a New Target Gene. UHOD , 2018 , 28 , 238-247
Rafet EREN, Muzaffer Ece HAKAN, Ceyda ASLAN, Mehmet Hilmi DOGU, Sermin ALTINDAL, Osman YOKUS, Elif SUYANI The Impact of Bulky Mass on Treatment Response and Overall Survival in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era. UHOD , 2018 , 28 , 248-253
Ayse Muge KARCIOGLU, Mufide OKAY, Yahya BUYUKASIK, Umit Yavuz MALKAN, Nilgun SAYINALP, Haluk DEMIROGLU, Hakan GOKER, Salih AKSU, Osman Ilhami OZCEBE, Ibrahim Celalettin HAZNEDAROGLU Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia. UHOD , 2018 , 28 , 254-260
Zeynep A. YEGIN, Mehmet S. PEPELER, Handan KAYHAN, Hakan KOSEBIYIKOGLU, Sanem GOKCEN, Lale A. KAYNAR, Munci YAGCI Cytoplasmic Nucleolin Expression in Chronic Lymphocytic Leukemia. UHOD , 2018 , 28 , 261-264
Yurday OZDEMIR, Ibrahim ACIBUCI, Erkan TOPKAN The Feasibility of Sparing the Hippocampus and Hypothalamic -Hypophysial Axis During Whole Brain Radiotherapy: A Dosimetric Study. UHOD , 2018 , 28 , 208-216
Ozlem YETMEN DOGAN, Elif GUZEL, Ilker COBAN, Oner SUZER, Nuran BESE Does Lapatinib Increase Pulmonary Toxicity when Concurrently Used with Radiation Therapy? An Experimental Study with Wistar-Albino Rats. UHOD , 2018 , 28 , 217-223
Ulas KUMBASAR, Melih OZERCAN, Sevilay KARAHAN, Erkan DIKMEN, Metin DEMIRCIN, Riza DOGAN Prognostic Significance of the Glasgow Prognostic Score in Patients Undergoing Pulmonary Metastasectomy. UHOD , 2018 , 28 , 224-229
Le Van QUANG, Nguyen Van HIEU, Nguyen Xuan HAU, Nguyen Van HUNG Role of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma in Vietnam. UHOD , 2018 , 28 , 230-237
Mahdiyar IRAVANI SAADI, Nargess ARANDI, Ramin YAGHOBI, Negar AZARPIRA, Bita GERAMIZADEH, Mani RAMZI Up-Regulation of the miR-92a and miR-181a in Patients with Acute Myeloid Leukemia and their Inhibition with Locked Nucleic acid (LNA)-antimiRNA; Introducing c-Kit as a New Target Gene. UHOD , 2018 , 28 , 238-247
Rafet EREN, Muzaffer Ece HAKAN, Ceyda ASLAN, Mehmet Hilmi DOGU, Sermin ALTINDAL, Osman YOKUS, Elif SUYANI The Impact of Bulky Mass on Treatment Response and Overall Survival in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era. UHOD , 2018 , 28 , 248-253
Ayse Muge KARCIOGLU, Mufide OKAY, Yahya BUYUKASIK, Umit Yavuz MALKAN, Nilgun SAYINALP, Haluk DEMIROGLU, Hakan GOKER, Salih AKSU, Osman Ilhami OZCEBE, Ibrahim Celalettin HAZNEDAROGLU Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia. UHOD , 2018 , 28 , 254-260
Zeynep A. YEGIN, Mehmet S. PEPELER, Handan KAYHAN, Hakan KOSEBIYIKOGLU, Sanem GOKCEN, Lale A. KAYNAR, Munci YAGCI Cytoplasmic Nucleolin Expression in Chronic Lymphocytic Leukemia. UHOD , 2018 , 28 , 261-264